News
Genetic differences that make some people susceptible to meningitis revealed in major new study
August 8, 2010 10:38 am | by EurekAlert | Comments(Imperial College London) Genetic differences that make some people susceptible to developing meningococcal meningitis and septicaemia, and others naturally immune, are revealed in a new study of over 6,000 people, published today in Nature Genetics. The research, led by Imperial...
Health care using telephone and telemonitoring technology benefits heart failure patients
August 7, 2010 4:37 pm | by EurekAlert | Comments(Wiley-Blackwell) Providing patients with chronic heart failure access to remote monitoring, for example by telephone or telemonitoring using wireless technology, reduces deaths and hospitalizations and may provide benefits on health care costs and quality of life. These are the...
Autism: Lack of evidence for antidepressants
August 7, 2010 4:37 pm | by EurekAlert | Comments(Wiley-Blackwell) Antidepressants commonly prescribed to people with autistic spectrum disorders cannot be recommended based on current evidence, a new study by Cochrane Researchers concludes. Despite some evidence of benefits in adults diagnosed with autism, they say there is no...
Emeritus says purchase of Sunwest homes complete
August 6, 2010 3:45 pm | by The Associated Press | CommentsEmeritus Corp. on Friday announced the near completion of a $1.2 billion acquisition of 144 assisted living homes from Sunwest Management Inc.The purchase was made through a joint venture that includes Emeritus, Blackstone Real Estate Advisors, an affiliate of The Blackstone Group and Columbia...
Izard Nobel LLP Announces Class Action Lawsuit Against Almost Family, Inc.
August 6, 2010 1:45 pm | by The Associated Press | CommentsThe law firm of Izard Nobel LLP, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Western District of Kentucky on behalf of...
Problems Delay NRU Repairs, Extend Shortage of Isotope
August 6, 2010 1:37 pm | by U.S. Food & Drug Administration | CommentsAfter some unforeseen delays, Canada’s National Research Universal (NRU) reactor may be able to resume production this month of molybdenum-99 (Mo-99), which is used to generate a widely used diagnostic.
ARJ Takes Down Its Website Following Warning Letter
August 6, 2010 1:37 pm | by U.S. Food & Drug Administration | CommentsAfter receiving a warning letter citing it for marketing unapproved pregnancy and drug screening tests on its website, ARJ Medical has pulled the site off the internet.
FDA rejects orphan status for DUSA drug
August 6, 2010 11:36 am | by Mass High Tech: The Journal of New England Technology | CommentsDUSA Pharmaceuticals Inc. has failed to receive orphan drug designation from the FDA for its Levulan Photodynamic Therapy (PDT) system for multiple medical indications, with a concentration on dermatology. As a result, the company will close out the its associated pilot clinical trial.
California Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People with Disabilities Under Medicare
August 6, 2010 11:35 am | by Bio-Medicine.Org | CommentsSACRAMENTO, Calif. , Aug. 6 /PRNewswire-USNewswire/ -- Providers of home medical equipment and services across California are proposing a fiscally responsible alternative to the mislabeled "competitive" bidding scheme currently under way in Medicare that will actually discourage...
Michigan Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People With Disabilities Under Medicare
August 6, 2010 11:35 am | by Bio-Medicine.Org | CommentsROCHESTER HILLS, Mich. , Aug. 6 /PRNewswire-USNewswire/ -- Providers of home medical equipment and services across Michigan are proposing a fiscally responsible alternative to the mislabeled "competitive" bidding scheme currently under way in Medicare that will actually discourage...
Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
August 6, 2010 10:36 am | by Bio-Medicine.Org | CommentsMOUNTAIN VIEW, Calif. , Aug. 6 /- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that company Senior Vice President and Chief Financial Officer, August J. Moretti will present during the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference. The...
Endo to Present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
August 6, 2010 10:33 am | by Bio-Medicine.Org | CommentsCHADDS FORD, Pa. , Aug. 6 /- Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that it will present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference on Thursday, August 12, 2010 , at 8:00 a.m. EDT . Alan Levin, executive vice president and chief...
Alphatec shares hit low after cutting sales view
August 6, 2010 9:45 am | by The Associated Press | CommentsShares of Alphatec Holdings Inc. plunged to a 52-week low Friday after the spinal device maker said sales are slowing down, and slashed its expectations for the rest of the year.In morning trading Alphatec shares dove $1.91, or 43.2 percent, to $2.51. Earlier they fell to an annual low of...
McKesson to open distribution center in Virginia
August 6, 2010 8:45 am | by The Associated Press | CommentsDrug distributor McKesson Corp. plans to open a distribution center in Caroline County, Va., that's expected to create 150 jobs.The new facility was announced Friday by McKesson officials, the Caroline County Board of Supervisors and Gov. Bob McDonnell.San Francisco-based McKesson will build...
Syndax takes in $6M for cancer therapeutics
August 6, 2010 6:38 am | by Mass High Tech: The Journal of New England Technology | CommentsSyndax Pharmaceuticals Inc., a cancer therapeutics developer in Waltham, has raised $6 million of a planned $7 million securities offering. The company makes an oral HDAC inhibitor that is designed to aid a cancer patient's response to treatment by modifying tumor characteristics.
